Bizarre Patents
Ballistic resistant body covering
A ballistic resistant body covering for protecting the torso, groin and neck area from ballistic missiles.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 4861592 | Pharmaceutical compositions A pharmaceutical composition suitable for oral adminstration comprising particulate cimetidine suspended in an aqueous phase containing a buffer which maintains the pH at greater than 7 and a suspending agent.... | 08/29/1989 |
| 4861771 | Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benz azepine as prodrugs Prodrug carbamate derivatives of fenoldopam which provide fenoldopam plasma levels of similar magnitude and over a much longer period of time than the parent compound. An absence of a high initial peak effect associated with the parent compound is noted. ... | 08/29/1989 |
| 4851443 | Carboxylic acid amides, compositions and medical use thereof Amide derivatives of non-steroidal anti-inflammatory carboxylic acids which have anti-inflammatory activity in their own right as well as being effective as pro-drugs of the carboxylic acids.... | 07/25/1989 |
| 4839371 | 3-aralkyl-2-mercaptoyridines as dopamine-ଲ-hydroxylase inhibitors Disclosed are novel substituted 3-aralkyl-2-mercaptopyridines of the structure: ##STR1## processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy in particul... | 06/13/1989 |
| 4835154 | 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-ଲhydroxylase inhibitors Potent dopamine-ଲ-hydroxylase inhibitors having the Formula ##STR1## that are useful to inhibit dopamine-ଲ-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopa... | 05/30/1989 |
| 4831018 | Polyene antibiotic emulsion formulation A polyene antibiotic emulsion formulation comprising a therapeutically effective amount of the antibiotic incorporated into an oil-in-water emulsion, and a method of treating an active infection in an animal caused by a microorganism with sterols in its c... | 05/16/1989 |
| 4826876 | Chemical compounds having selective thyromimetic activity This invention relates to chemical compounds which have selective thyromimetic activity. A compound of this invention is 3,5-dibromo-3'-[6-oxo-3(1H)-pyridazinyl-methyl]-thyronine.... | 05/02/1989 |
| 4826813 | 4'-Methyl-ଲ-mercapto-ଲ,ଲ-cyclopentamethylenepropionic acid vasopressin antagonists Vasopressin antagonists which have a 4'-methyl-ଲ-mercapto-ଲ,ଲ-cyclopentamethylenepropionic acid group have vasopressin antagonist activity without substantial agonist activity. A species of the invention is [1-(4'-methyl-ଲ-mer... | 05/02/1989 |
| 4824664 | Effervescent couples, histamine H2 -antagonist effervescent compositions containing them and their preparation The invention relates to an effervescent couple which comprises a mixture of mono-and di-alkali metal citrate as well as to a process for preparing same. The process comprises partially neutralizing citric acid by reacting an alkali metal carbonate or bic... | 04/25/1989 |
| 4820819 | 5-phenyl-3[2H]-pyridazinone derivatives This invention relates to (isopropyl and tertiary butyl-amino-2-hydroxypropoxy)phenyl-3[2H]-pyridazinones which have ଲ-adrenoceptor antagonist activity.... | 04/11/1989 |
| 4820708 | Pyrimidylalkylthio benzimidazole compounds, pharmaceutical compositions and use This invention relates to 2- and 4-pyrimidinylmethylsulphinyl(and thio)benzimidazoles in which the pyrimidyl group is substituted by an optionally substituted amino group. These compounds inhibit exogenously and endogenously stimulated gastric acid secret... | 04/11/1989 |
| 4810778 | Intermediates for preparing 1,6-dicarba-vasopressin compounds New compounds which have potent V2 -vasopressin antagonistic activity are prepared by a 1,6-cyclization using peptide bond formation. The structures of the compounds are characterized by the Pas1,6 or Tas1,6 cyclized unit.... | 03/07/1989 |
| 4803279 | 1.4-dihydro-4-pyridyl-substituted imidazo (2,1-b) thiazoles and the corresponding thiazines. 6-Aryl-2,3-dihydroimidazo[2,1-b]thiazoles and corresponding thiazines act as nucleophiles, either directly or in the form of Grignard reagents, with N-acylpyridinium salts to produce new 6-aryl-5-(N-acyl-1,4-dihydro-4-pyridyl)-2,3-dihydroimidazo-[2,1-b]th... | 02/07/1989 |
| 4789629 | Method and device for collecting and testing for fecal occult blood A method and slide for collecting and testing fecal occult blood which permits multiple analyses of a single fecal sample. The slide contains a pocket-like member on a portion of the inside front cover of the slide. An absorbent insert is disposed in the ... | 12/06/1988 |
| 4786735 | Process for preparing cimetidine polymorph B A novel process for preparing cimetidine polymorph "B" comprises precipitating cimetidine from an aqueous-alcoholic solution of an acid addition salt. The precipitation is conducted at a temperature of above 15° C.... | 11/22/1988 |
| 4786651 | Treatment of cutaneous hyperproliferative dermatoses with manoalide Manoalide and its derivatives are useful in the treatment of cutaneous hyperproliferative dermatoses.... | 11/22/1988 |
| 4783487 | N-(1-carboxy-2-hydroxy-5-phenyl)-2-(6-methoxy-2-naphthyl)propionamide and anti-inflammatory use thereof Amide derivatives of non-steroidal anti-inflammatory carboxylic acids which have anti-inflammatory activity in their own right as well as being effective as pro-drugs of the carboxylic acids.... | 11/08/1988 |
| 4782163 | 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)-oxazolidines New intermediates, namely 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)-oxazolidines, are prepared by a synthetic sequence which uses a Darzen's reaction in a homogeneous solvent system.... | 11/01/1988 |
| 4772723 | Dopamine ଲ-hydroxylase inhibitors Potent DBH Inhibitors having the formula: ##STR1## wherein R is --CO2 H or --CH2 NHR1 can be used to inhibit DBH activity in mammals.... | 09/20/1988 |
| 4769368 | 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines 2,3,4,8,9,9a-Hexahydro-4-aryl-1H-indeno[1,7-cd;]-azepines are selective dopamine receptor site binding agents.... | 09/06/1988 |
| 4769386 | Imidazolylthioalkenoic acids and -alkenols and leukotriene antagonistic composition containing them The imidazolylthio substituted alkanoic acids represented by the formula (I) or (IA) as defined herein have been found to be leukotriene antagonists and useful in the treatment of diseases in which leukotrienes are a factor, such as asthma.... | 09/06/1988 |
| 4767862 | Substituted tetrahydro isoquinoline intermediates Compounds having the formula ##STR1## are ଲ-adrenergic receptor antagonists. Also disclosed are pharmaceutical compositions and methods for producing ଲ-adrenergic receptor antagonistic activity in animals including man.... | 08/30/1988 |
| 4766108 | Tyr-Arg-vasopressin antagonists Vasopressin antagonists which have a dipeptide tail composed of a neutral and basic amino acid unit demonstrate potent V1 and V2 -antagonist activity. Two species of this invention, which are prepared by solid phase peptide synthesis... | 08/23/1988 |
| 4762850 | Dopamine-beta-hydroxylase inhibitors Potent dopamine-ଲ-hydroxylase inhibitors having the Formula ##STR1## that are useful to inhibit dopamine-ଲ-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopa... | 08/09/1988 |
| 4762701 | In vivo cellular tracking Methods of tracking cells in vivo and for determining in vivo cell lifetimes. Cells are labelled with cyanine dyes and detection is by measuring fluorescence, absorbance, or by detecting nuclear magnetic resonance probes included in the cyanine dyes. Usin... | 08/09/1988 |
| 4761480 | P-toluene-sulfonyl-oxy substituted pyridines Potent dopamine-ଲ-hydroxylase inhibitors having the Formula: ##STR1## which are useful to inhibit dopamine-ଲ-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit do... | 08/02/1988 |
| 4761415 | Dopamine-ଲ-hydroxylase inhibitors Potent dopamine-ଲ-hydroxylase inhibitors having the Formula ##STR1## that are useful to inhibit dopamine-ଲ-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopa... | 08/02/1988 |
| 4760089 | Irreversible dopamine-ଲ-hydroxylase inhibitors Potent, irreversible dopamine-ଲ-hydroxylase inhibitors having the Formula: ##STR1## which are useful to inhibit dopamine-ଲ-hydroxylase activity, pharmaceutical compositions including these inhibitors or 2-cyano-2-phenethylamine, and ... | 07/26/1988 |
| 4760052 | 1,6-dicarba-vasopressin compounds New compounds which have potent V2 -vasopressin antagonistic activity are prepared by a 1,6-cyclization using peptide bond formation. The structures of the compounds are characterized by a Pas1,6 or Tas1,6 cyclized unit. A... | 07/26/1988 |
| 4755511 | Tricyclic pyridazinone compounds This invention relates to tricyclic pyridazinone compounds, pharmaceutical compositions containing the compounds, and a method of stimulating cardiac activity in a mammal by administering an effective amount of the compound. A compound of the invention is... | 07/05/1988 |
| 4755507 | Method of treating benign prostatic hypertrophy Method of producing symptomatic relief in benign prostatic hypertrophy by administering 3-alkyl-6-halo-2,3,4,5-tetrahydro-1H-3-benzazepines.... | 07/05/1988 |
| 4749717 | Dopamine-beta-hydroxylase inhibitors Potent dopamine-ଲ-hydroxylase inhibitors having the Formula ##STR1## that are useful to inhibit dopamine-ଲ-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopa... | 06/07/1988 |
| 4749782 | Vasopressin compounds Certain vasopressin-like compounds whose structures have a ଲ,ଲ-diethyl-ଲ-mercaptopropionic acid at position 1 have unexpectedly potent V2 -antagonist activity. A species of the group is [1-ଲ,ଲ-diethyl-ଲ-merca... | 06/07/1988 |
| 4743613 | Ester prodrugs of dopamine-ଲ-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-ଲ-hydroxylase activity Compounds having the formula: ##STR1## which are ester prodrugs of potent dopamine-ଲ-hydroxylase inhibitors and thus are useful to inhibit dopamine-ଲ-hydroxylase activity, pharmeceutical compositions including these compounds, and methods... | 05/10/1988 |
| 4743588 | Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents Compositions and methods useful for enhancing the transdermal and transmembrane drug delivery of topical and systemic agents. The compositions and methods comprise the active agent together with an effective amount of certain amides of heterocyclic amines... | 05/10/1988 |
| 4728741 | 1-substituted-2-mercapto benzimidazole compounds and intermediates 1-substituted-2-mercapto(or aminomethyl)benzimidazole compounds of the formula ##STR1## inhibit dopamine-ଲ-hydroxylase activity. Intermediates are also disclosed.... | 03/01/1988 |
| 4728656 | 2,2-alkyldiylbis(thio)bis(imidazoles) useful for inhibition of the 5-lipoxygenase pathway Novel compounds, pharmaceutical compositions and a method of inhibiting the 5-lipoxygenase products in an animal in need thereof which comprises administering an effective, 5-lipoxygenase pathway inhibiting amount of a 2,2'-[1,2-ethanediylbis-(thio)]-bis-... | 03/01/1988 |
| 4724973 | Tamper evident container seal A tamper evident seal for containers having a plastic shrink sleeve placed around the cap and neck and extending over the shoulder. A paper label is placed over a portion of the sleeve to prevent the sleeve from being removed intact. The sleeve has zigzag... | 02/16/1988 |
| 4724229 | Arg-arg-arg-vasopressin antagonists Vasopressin antagonists which have a tripeptide side chain comprised of three basic amino acids, such as arginine, lysine or ornithine, demonstrate potent V1 and V2 -antagonist activity. A species of the invention, which is prepared ... | 02/09/1988 |
| 4719222 | Pharmacologically active 5-oxo-1-imidazolidine acetamide compounds The invention relates to 5-oxo-1-imidazolidineacetamide derivatives which help restore learning and memory difficulties associated with ageing. A compound of the invention is 2,2-dimethyl-5-oxo-1-imidazolidineacetamide.... | 01/12/1988 |
